文献速递关节外科骨质疏松与代谢性骨病

胰岛素依赖型糖尿病患者行全关节置换术后高血糖风险增加

Insulin-Dependent Diabetic Patients are at Increased Risk of Postoperative Hyperglycemia When Undergoing Total Joint Arthroplasty.
PubMed 文献 · J Arthroplasty · 2020-04-30

该回顾性研究纳入2011至2016年行全髋或全膝关节置换的773例糖尿病患者,比较胰岛素依赖型(IDDM)与非胰岛素依赖型(NIDDM)的术后高血糖和假体周围感染(PJI)风险。IDDM患者术前A1c和术后血糖更高,术后高血糖>200 mg/dL风险显著增加(OR 5.2),但PJI无差异。

要点

  • IDDM患者术后高血糖>200 mg/dL风险是NIDDM的5.2倍。
  • IDDM与NIDDM的PJI发生率无显著差异(2.52% vs 2.38%)。
  • IDDM预测术后高血糖的A1c阈值为>6.59%,NIDDM为>6.60%。

核心结论

  • IDDM患者行全关节置换术后发生高血糖>200 mg/dL的风险是NIDDM患者的5.2倍,但本研究未发现PJI风险增加。

主要发现

  • IDDM组术前A1c为6.97%,高于NIDDM组的6.28%(P < .0001)。
  • IDDM组术后血糖为235.2,高于NIDDM组的163.5(P < .0001)。
  • IDDM组术后高血糖发生率为63.84%,NIDDM组为20.83%(P < .0001;OR 5.2;95%CI 3.66-7.4)。
  • 总体A1c >7.45%预测术后高血糖>200 mg/mL(OR 6.94;95%CI 4.32-11.45)。
  • IDDM组A1c >6.59%、NIDDM组A1c >6.60%与术后高血糖风险增加相关(P < .0001)。

关键数值与推荐

  • 术后高血糖定义为>200 mg/dL。
  • IDDM预测术后高血糖的A1c阈值为>6.59%,NIDDM为>6.60%。
  • 总体预测术后高血糖的A1c阈值为>7.45%。

临床怎么用

  • 对IDDM患者行全关节置换术应加强围手术期血糖监测与控制。
  • IDDM患者A1c >6.59%时需警惕术后高血糖风险。
  • NIDDM患者A1c >6.60%时也应关注术后高血糖。

局限性

  • 本研究为回顾性设计。
  • 本研究未发现IDDM与NIDDM的PJI差异,可能受样本量限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetic patients are at an increased risk of prosthetic joint infection (PJI) after total joint arthroplasty (TJA). The relationship between insulin-dependence and PJI has not been investigated. We aimed at evaluating whether insulin-dependent diabetes mellitus (IDDM) patients were more susceptible to postoperative hyperglycemia and PJI than their non-insulin-dependent diabetes mellitus (NIDDM) counterparts. METHODS: A retrospective review was conducted of diabetic patients undergoing TJA (hip or knee) from January 2011 to December 2016. Preoperative hemoglobin A1c (A1c) and postoperative glucose measurements were observed. Patients were stratified as IDDM or NIDDM. The A1c values that predicted hyperglycemia >200 mg/dL for each group were calculated. Primary end point was postoperative hyperglycemia >200 mg/dL and secondary end point was PJI. RESULTS: There were 773 patients meeting inclusion criteria. The IDDM cohort had a higher preoperative A1c (6.97% vs 6.28%, P < .0001) and postoperative glucose (235.2 vs 163.5, P < .0001). IDDM patients were more likely to have postoperative hyperglycemia (63.84% vs 20.83%, P < .0001; odds ratio, 5.2; 95% confidence interval, 3.66-7.4). Overall, an A1c of >7.45% predicted postoperative hyperglycemia >200 mg/mL (odds ratio, 6.94; 95% confidence interval, 4.32-11.45). When separating our 2 cohorts, an A1c of >6.59% in IDDM, and >6.60% in NIDDM, was associated with an increased risk of postoperative hyperglycemia (P < .0001). PJI was similar between the 2 cohorts (2.52% vs 2.38%, P = .9034). CONCLUSION: IDDM patients undergoing TJA are 5.2 times more likely to have postoperative hyperglycemia >200 mg/dL than their NIDDM counterparts, although increased risk of PJI was not found in this study. Despite the higher A1c and postoperative hyperglycemia in IDDM patients, there was found to be no clinical difference between A1c cutoff values for postoperative hyperglycemia between IDDM and NIDDM patients.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Godshaw BM, Warren MS, Nammour MA, et al. Insulin-Dependent Diabetic Patients are at Increased Risk of Postoperative Hyperglycemia When Undergoing Total Joint Arthroplasty. J Arthroplasty. 2020. PMID: 32448493. doi:10.1016/j.arth.2020.04.082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。